Insulet, headquartered in Acton, Massachusetts, develops and markets insulin infusion systems, including the Omnipod 5 Automated Insulin Delivery System, for insulin-dependent diabetes. The company employs 3,000 staff and went public in 2007.
PODD has been in the news recently: Insulet (NASDAQ: PODD) disclosed fourth-quarter earnings on Wednesday, February 18, 2026, at 7:00 AM. Shares rose after the company reported better-than-expected Q4 results and raised its 2026 guidance.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.